Future Optimal Research and Care Evaluation - Aortic Stenosis

Launched by ST. ANTONIUS HOSPITAL · Dec 4, 2023

Keywords

ClinConnect Summary

This clinical trial, called the Future Optimal Research and Care Evaluation for Aortic Stenosis, is studying different treatment options for patients with severe or moderate aortic valve stenosis. Aortic valve stenosis is a condition where the valve that helps blood flow from the heart to the rest of the body becomes narrow, which can lead to serious heart problems. The trial aims to understand how different treatments—surgical aortic valve replacement (SAVR), transcatheter aortic valve implantation (TAVI), or conservative care—affect patients' quality of life and survival over time.

Anyone over 18 years old with severe or moderate aortic stenosis may be eligible to participate. The trial is currently recruiting participants, and it welcomes individuals of all genders. If you join the study, you can expect to share information about your health and treatment experiences, which will help doctors learn more about the best ways to manage this condition. This research is important as it could help doctors provide better care tailored to each patient's needs.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Older than 18 years of age
• • Severe or moderate aortic stenosis
• • No exclusion criteria are applicable to this registry